Israel And Pfizer: The Attack We Can't Talk About
Discover more from The Stark Naked Brief.
Israel And Pfizer: The Attack We Can't Talk About
Some perspective.
The last week or so has brought about a marked change.
Until the horrific Hamas attack, Israel was fair game. Now, since the world has divided itself into opposing factions, nuanced criticism has become “racism”. Certain topics are now off limits or brushed under the carpet altogether.
One of these is what Pharma Research and Development executive Sascha Latypova presents as an attack the Israeli government carried out on its own citizens in collaboration with Pfizer.
In 1996, Pfizer conducted a clinical trial involving an experimental drug on 200 Nigerian children. The parents were not informed that their children were part of an experimental study. Following the trial, eleven children died and several others experienced severe side effects, including brain damage and organ failure.
Nigeria’s health ministry released a report which labelled the trial as "illegal" for using an "unregistered drug." The report further criticised Pfizer for "exploiting the ignorant" and for violating both Nigerian and international laws. Pfizer failed to obtain the necessary consent and did not notify patients that their children were subjects in an experiment rather than recipients of an approved medication.
In 2002, Pfizer settled a lawsuit for $49 million following allegations that its subsidiary, Parke-Davis Labs, overcharged Medicaid for its cholesterol-lowering drug, Lipitor. The Justice Department (DoJ) accused Parke-Davis Labs of inaccurately reporting the best price for Lipitor during the first two quarters of 1999.
Pfizer acquired Parke-Davis in 2000 as part of its purchase of Warner-Lambert. In 2001, Lipitor recorded sales of $6.45 billion. According to the DoJ, the concealed discounts enabled Parke-Davis/Warner-Lambert to withhold over $20 million in rebates that should have gone to Medicaid. Pfizer had to agree to a five-year corporate integrity agreement intended to prevent future issues.
In 2008, The New York Times released an extensive exposé, alleging that Pfizer manipulated the publication of scientific studies in the early 2000s to support the use of its epilepsy drug, Neurontin. This came after experts reviewed thousands of company documents as part of a lawsuit against Pfizer.
The company's strategies reportedly included delaying the release of studies that did not find supportive evidence of the drug's efficacy for other disorders, presenting negative data favourably, and combining unfavourable results with positive ones to neuter the appearance of negative impacts.
In 2004, Pfizer halted its marketing campaign for Neurontin when a generic version became available. That same year, Pfizer settled federal criminal and civil allegations for $430 million.
Despite all of this, the Israeli government became “the lab for Pfizer” as Prime Minister of Israel, Benjamin Netanyahu, said in an interview with Dr. Jordan Peterson in December 2022.
Documents recently released after a prolonged legal battle further confirm Israel’s ‘dark lab’ status. The Israeli Ministry of Health (IMOH) had signed four significant agreements with Pfizer before the vaccine acquired Emergency Use Authorization (EUA) from the FDA. But the government allegedly concealed the actual signing dates, implying the vaccine had received international approvals earlier than it had.
The key agreements with Pfizer were:
Real-World Epidemiological Evidence Collaboration Agreement (Released as the "Israel-Pfizer Agreement"): Signed on December 1, 2020, this agreement outlines the sharing of information between Israel and Pfizer regarding the study of the vaccine's impact on the Israeli population. The objective was to analyse the data arising from the vaccination drive in Israel, primarily to ascertain the possibility of achieving herd immunity. This signing date was found to be approximately five weeks earlier than previously claimed by the IMOH.
Manufacturing and Supply Agreement: Disclosed for the first time, this contract, also signed on December 1, 2020, details the production and supply terms for the vaccine.
Confidentiality Agreement: This was signed on July 12, 2020, months before Pfizer began its Phase 3 trials and even before the company applied for the vaccine's approval.
Principles Document: Executed on November 13, 2020, this document laid down the foundational principles for the collaboration.
In short, the Israeli population was subject to medical experimentation without full and informed consent.
This was a reality the country started to bear the consequences of as early as April 2021 when IMOH flagged a safety signal for heart complications, particularly among younger men. Nearly two months after the government imposed vaccine passports or what they called “green passes”.
By August 2021, researchers found through analysing large anonymised patient records from Israel that natural immunity was stronger and longer-lasting compared to Covid vaccination. Of the 257 positive cases reviewed, the researchers detected 93% in the vaccinated group, and only 7% in the previously infected group. Additionally, out of nine hospitalisations, eight occurred in the vaccinated group, compared to just one in the previously infected group.
Another group of researchers reached a near identical conclusion, again using Israeli data, in another observational study conducted two months later.
Israel arguably became a trial site for one of the most of corrupt Big Pharma companies in the world for little to no benefit, keeping their citizenry in the dark and putting their health in danger while coercing them all along the way.
If that doesn’t constitute a form of attack what does?
Israel And Pfizer: The Attack We Can't Talk About
I remember being horrified at the time, when almost the entire country was being injected by the experiment, and wondering why the Israelis were the guinea pigs volunteered by their own government 😕
The contract with South Africa: Pfizer doesn't know efficacy or side-effects - absolved of any responsibility.